222 related articles for article (PubMed ID: 16331887)
1. The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells.
Zeidler M; Varambally S; Cao Q; Chinnaiyan AM; Ferguson DO; Merajver SD; Kleer CG
Neoplasia; 2005 Nov; 7(11):1011-9. PubMed ID: 16331887
[TBL] [Abstract][Full Text] [Related]
2. The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer.
Zeidler M; Kleer CG
J Mol Histol; 2006 Sep; 37(5-7):219-23. PubMed ID: 16855786
[TBL] [Abstract][Full Text] [Related]
3. Interactions involving the Rad51 paralogs Rad51C and XRCC3 in human cells.
Wiese C; Collins DW; Albala JS; Thompson LH; Kronenberg A; Schild D
Nucleic Acids Res; 2002 Feb; 30(4):1001-8. PubMed ID: 11842112
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs in human cells.
Liu N; Schild D; Thelen MP; Thompson LH
Nucleic Acids Res; 2002 Feb; 30(4):1009-15. PubMed ID: 11842113
[TBL] [Abstract][Full Text] [Related]
5. Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells.
Fujii S; Ochiai A
Cancer Sci; 2008 Apr; 99(4):738-46. PubMed ID: 18377425
[TBL] [Abstract][Full Text] [Related]
6. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling.
Chang CJ; Yang JY; Xia W; Chen CT; Xie X; Chao CH; Woodward WA; Hsu JM; Hortobagyi GN; Hung MC
Cancer Cell; 2011 Jan; 19(1):86-100. PubMed ID: 21215703
[TBL] [Abstract][Full Text] [Related]
7. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.
Kleer CG; Cao Q; Varambally S; Shen R; Ota I; Tomlins SA; Ghosh D; Sewalt RG; Otte AP; Hayes DF; Sabel MS; Livant D; Weiss SJ; Rubin MA; Chinnaiyan AM
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11606-11. PubMed ID: 14500907
[TBL] [Abstract][Full Text] [Related]
8. Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers.
Lee ST; Li Z; Wu Z; Aau M; Guan P; Karuturi RK; Liou YC; Yu Q
Mol Cell; 2011 Sep; 43(5):798-810. PubMed ID: 21884980
[TBL] [Abstract][Full Text] [Related]
9. Complex formation by the human Rad51B and Rad51C DNA repair proteins and their activities in vitro.
Lio YC; Mazin AV; Kowalczykowski SC; Chen DJ
J Biol Chem; 2003 Jan; 278(4):2469-78. PubMed ID: 12427746
[TBL] [Abstract][Full Text] [Related]
10. Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells.
Shi B; Liang J; Yang X; Wang Y; Zhao Y; Wu H; Sun L; Zhang Y; Chen Y; Li R; Zhang Y; Hong M; Shang Y
Mol Cell Biol; 2007 Jul; 27(14):5105-19. PubMed ID: 17502350
[TBL] [Abstract][Full Text] [Related]
11. Xrcc3 is recruited to DNA double strand breaks early and independent of Rad51.
Forget AL; Bennett BT; Knight KL
J Cell Biochem; 2004 Oct; 93(3):429-36. PubMed ID: 15372620
[TBL] [Abstract][Full Text] [Related]
12. Polycomb group protein enhancer of zeste 2 is an oncogene that promotes the neoplastic transformation of a benign prostatic epithelial cell line.
Karanikolas BD; Figueiredo ML; Wu L
Mol Cancer Res; 2009 Sep; 7(9):1456-65. PubMed ID: 19723877
[TBL] [Abstract][Full Text] [Related]
13. EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells.
Stefansson OA; Esteller M
Breast Cancer Res; 2011 May; 13(3):309. PubMed ID: 21672285
[TBL] [Abstract][Full Text] [Related]
14. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder.
Raman JD; Mongan NP; Tickoo SK; Boorjian SA; Scherr DS; Gudas LJ
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8570-6. PubMed ID: 16361539
[TBL] [Abstract][Full Text] [Related]
17. The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine Fibroids.
Yang Q; Nair S; Laknaur A; Ismail N; Diamond MP; Al-Hendy A
Biol Reprod; 2016 Mar; 94(3):69. PubMed ID: 26888970
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer.
Reijm EA; Jansen MP; Ruigrok-Ritstier K; van Staveren IL; Look MP; van Gelder ME; Sieuwerts AM; Sleijfer S; Foekens JA; Berns EM
Breast Cancer Res Treat; 2011 Jan; 125(2):387-94. PubMed ID: 20306127
[TBL] [Abstract][Full Text] [Related]
19. The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer.
Saramäki OR; Tammela TL; Martikainen PM; Vessella RL; Visakorpi T
Genes Chromosomes Cancer; 2006 Jul; 45(7):639-45. PubMed ID: 16575874
[TBL] [Abstract][Full Text] [Related]
20. Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and invasion in cervical cancer.
Fang J; Zhang M; Li Q
Am J Med Sci; 2011 Sep; 342(3):198-204. PubMed ID: 21629038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
